AquaBounty Technologies (NASDAQ:AQB) Stock Price Crosses Below 50 Day Moving Average – What’s Next?

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report)’s stock price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $0.99 and traded as low as $0.89. AquaBounty Technologies shares last traded at $0.9899, with a volume of 49,163 shares.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a research note on Wednesday, July 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

Check Out Our Latest Stock Analysis on AQB

AquaBounty Technologies Stock Performance

The company has a fifty day moving average price of $0.99 and a two-hundred day moving average price of $0.95. The company has a market cap of $5.10 million, a P/E ratio of -0.83 and a beta of 1.39.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in AquaBounty Technologies stock. Two Sigma Investments LP acquired a new position in shares of AquaBounty Technologies, Inc. (NASDAQ:AQBFree Report) during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 37,565 shares of the company’s stock, valued at approximately $84,000. Two Sigma Investments LP owned approximately 0.97% of AquaBounty Technologies as of its most recent SEC filing. Hedge funds and other institutional investors own 8.92% of the company’s stock.

About AquaBounty Technologies

(Get Free Report)

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.

See Also

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.